A study led by a scientific team at Beth Israel Deaconess Medical Center (BIDMC) provides another important step in our understanding of the critical role the brain's molecular pathways play in the development of obesity and related disorders.

The findings identify for the first time the neuronal pathways that help keep body weight stable diverge at the melanocortin-4 receptor (MC4R) to regulate either food consumption or energy expenditure

A new poll reveals one-third of older Americans are not only having sweet dreams at night, but sleeping well, too. In addition, a Gallup polls shows men over 50 are getting the most out of their shut-eye.

The poll also shows sleep is never completely peaceful for 8 percent of adults, while the remainder lose at least one night a week, according to results released today by the International Longevity Center-USA, a New York-based non-profit policy group

With Halloween upon us, this year's holiday season is rapidly approaching, and recognizing the stress Americans are under, the Anxiety Disorders Association of America (ADAA) has created the first-ever National Stress Out Week from November 7 to 14.

In addition to encouraging Americans to relax and learn to manage their stress, National Stress Out Week will educate the public about the difference between anxiety and an anxiety disorder

Shire Pharmaceuticals Inc. presents new data demonstrating that the drug Adderall XR significantly improves symptoms in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

Nearly 75-percent of study participants experienced improvement in ADHD symptoms, according to preliminary results of the Quality of Life, Effectiveness, Safety, and Tolerability (Qu.E.S.T.) study, presented at the annual meeting of Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)

Shire Pharmaceuticals Inc. unveils new data demonstrating highly prescribed children' drug Adderall significantly improves symptoms in adults with attention deficit-hyperactivity disorder (ADHD).

Nearly 75-percent of study participants experienced improvement in ADHD symptoms, according to preliminary results of the Quality of Life, Effectiveness, Safety, and Tolerability (Qu.E.S.T.) study, presented the data at the annual meeting of Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)